From: Nerve conduction study of the association between glycemic variability and diabetes neuropathy
r | Spearman ρ | p value | |
---|---|---|---|
Age (years) | 0.028 | 0.86 | |
Disease duration (years) | 0.462 | 0.003 | |
HbA1c (%) | 0.292 | 0.067 | |
BMI (kg/m2) | − 0.39 | 0.012 | |
SBP (mmHg) | 0.045 | 0.78 | |
TG (mg/dL) | − 0.18 | 0.27 | |
LDL (mg/dL) | 0.40 | 0.011 | |
eGFR (mL/min/1.73 m2) | 0.014 | 0.70 | |
UAE (mg/gCre) | 0.13 | 0.41 | |
Median CMAP amp (mV) | − 0.098 | 0.55 | |
Median DL (m/s) | 0.032 | 0.84 | |
Median MCV (m/s) | − 0.27 | 0.088 | |
Median F latency z score | 0.057 | 0.72 | |
Median wrist SNAP (µV) | − 0.228 | 0.158 | |
Median SCV (m/s) | − 0.00 | 0.99 | |
Tibial CMAP amp (mV) | 0.12 | 0.46 | |
Tibial MCV (m/s) | − 0.043 | 0.79 | |
Tibial F z score | − 0.25 | 0.12 | |
Sural SNAP (µV) | − 0.15 | 0.37 | |
Sural SCV (m/s) | 0.055 | 0.74 | |
Medial plantar CNAP amp (µV) | − 0.32 | 0.042 | |
Medial plantar NCV (m/s) | − 0.033 | 0.849 |